METTL3/YTHDF1 m6A axis promotes tumorigenesis by enhancing DDR2 expression in ovarian cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference22 articles.
1. Wang Y.C., Tian J.Y., Han Y.Y., Liu Y.F., Chen S.Y., Guo F.J. Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies. Front Oncol. 2022;12:978603. Epub 2022/09/23. doi: 10.3389/fonc.2022.978603. PubMed PMID: 36132133; PubMed Central PMCID: PMCPMC9483181.
2. Liberto J.M., Chen S.Y., Shih I.M., Wang T.H., Wang T.L., Pisanic T.R., 2nd. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review. Cancers (Basel). 2022;14(12). Epub 2022/06/25. doi: 10.3390/cancers14122885. PubMed PMID: 35740550; PubMed Central PMCID: PMCPMC9221480.
3. Xiao Y., Bi M., Guo H., Li M. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. EBioMedicine. 2022;79:104001. Epub 2022/04/20. doi: 10.1016/j.ebiom.2022.104001. PubMed PMID: 35439677; PubMed Central PMCID: PMCPMC9035645.
4. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
5. Targeting N6-methyladenosine RNA modification combined with immune checkpoint inhibitors: a new approach for cancer therapy;Liu;Comput. Struct. Biotechnol. J.,2022
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo;European Journal of Medical Research;2024-08-05
2. ALKBH5 SUMOylation-mediated FBXW7 m6A modification regulates alveolar cells senescence during 1-nitropyrene-induced pulmonary fibrosis;Journal of Hazardous Materials;2024-04
3. Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects;Frontiers in Oncology;2024-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3